These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 13903907)
1. A comparative study of 5-fluorouracil (FU), 5-fluorodeoxyuridine (FUDR), and methotrexate (MTX)-progress report. HALL TC Cancer Chemother Rep; 1962 Feb; 16():391-6. PubMed ID: 13903907 [No Abstract] [Full Text] [Related]
2. The clinical evaluation of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in solid tumors in adults: a progress report. YOUNG CW; ELLISON RR; SULLIVAN RD; LEVICK SN; KAUFMAN R; MILLER E; WOLDOW I; ESCHER G; LI MC; KARNOFSKY DA; BURCHENAL JH Cancer Chemother Rep; 1960 Feb; 6():17-20. PubMed ID: 13846613 [No Abstract] [Full Text] [Related]
3. The clinical effects of the continuous intravenous and intra-arterial infusion of cancer chemotherapeutic compounds. SULLIVAN RD; MILLER E; CHRYSSOCHOOS T; WATKINS E Cancer Chemother Rep; 1962 Feb; 16():499-510. PubMed ID: 13918324 [No Abstract] [Full Text] [Related]
4. Comparison of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in the treatment of far-advanced breast and colon lesions. CURRERI AR; ANSFIELD FJ Cancer Chemother Rep; 1962 Feb; 16():387-8. PubMed ID: 13882717 [No Abstract] [Full Text] [Related]
5. The clinical excursion into 5-fluo-rouracil. SCHNEIDERMAN MA Cancer Chemother Rep; 1962 Feb; 16():107-118. PubMed ID: 13908975 [No Abstract] [Full Text] [Related]
6. Studies on the feasibility of adjuvant chemotherapy with 5-fluorouracil (FU) and 5-fluoro-2'-deoxyuridine (FUDR) in the immediate postoperative period. JOHNSON RO; WOLBERG WH; CURRERI AR Arch Surg; 1962 Jul; 85():81-4. PubMed ID: 14452103 [No Abstract] [Full Text] [Related]
7. CLINICAL INVESTIGATIONS IN CANCER CHEMOTHERAPY. SULLIVAN RD; WATKINS E; ZUREK WZ Lahey Clin Found Bull; 1964; 13():113-20. PubMed ID: 14163652 [No Abstract] [Full Text] [Related]
8. Rate-limiting steps in the interactions of fluoropyrimidines and methotrexate. Bowen D; Bailey BD; Guernsey LA Eur J Cancer Clin Oncol; 1984 May; 20(5):651-7. PubMed ID: 6234172 [TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of the pyrimidine nucleosides 5-fluoro-2'-deoxyuridine and 5-iodo-2'-deoxyuridine. PAPAC R; JACOBS E; WONG F; COLLOM A; SKOOG W; WOOD DA Cancer Chemother Rep; 1962 Jul; 20():143-6. PubMed ID: 14483657 [No Abstract] [Full Text] [Related]
10. Clinical studies with 5-fluoro-2'-deoxyuridine. ANSFIELD FJ; CURRERI AR Cancer Chemother Rep; 1960 Feb; 6():21-5. PubMed ID: 13793784 [No Abstract] [Full Text] [Related]
11. [Chemotherapy of malignant tumors in gynecology; a report on therapy with azauridine (6-azauracilriboside)]. KAFKA V; MUSIL J; PADOVEC J; SORM F Gynaecologia; 1961; 152():191-7. PubMed ID: 13791284 [No Abstract] [Full Text] [Related]
12. Clinical experience with 5-fluoro-2'-deoxyuridine. MOORE GE; KOIKE A Cancer Chemother Rep; 1960 Feb; 6():26-8. PubMed ID: 14423850 [No Abstract] [Full Text] [Related]
13. Pilot study of 6-azauridine in children with advanced solidneoplasms. DELTA BG; PINKEL D Cancer Chemother Rep; 1961 Apr; 11():143-4. PubMed ID: 13721704 [No Abstract] [Full Text] [Related]
14. Selection of patients for evaluation of chemotherapeutic procedures in advanced cancer. KARNOFSKY DA; ELLISON RR; GOLBEY RB Cancer Chemother Rep; 1962 Feb; 16():73-7. PubMed ID: 14454017 [No Abstract] [Full Text] [Related]
15. A preliminary comparison of 5-fluoro-2'-deoxyuridine administered by rapid daily intravenous injections and by slow continuous infusion. ANSFIELD FJ; SCHROEDER JM; CURRERI AR Cancer Chemother Rep; 1962 Feb; 16():389-90. PubMed ID: 13861732 [No Abstract] [Full Text] [Related]
16. PYRIMIDINE METABOLISM IN TISSUE CULTURE CELLS DERIVED FROM RAT HEPATOMAS. I. SUSPENSION CELL CULTURES DERIVED FROM THE NOVIKOFF HEPATOMA. MORSE PA; POTTER VR Cancer Res; 1965 May; 25():499-508. PubMed ID: 14297488 [No Abstract] [Full Text] [Related]
17. Regional protection in cancer chemotherapy. II. Preliminary studies with hypogastric artery infusion of thymidine during treatment with 5-iodo-2'-deoxyuridine. MARK JB; CALABRESI P Cancer Chemother Rep; 1962 Feb; 16():545-51. PubMed ID: 14469946 [No Abstract] [Full Text] [Related]
18. Important role of the dihydrouracil/uracil ratio in marked interpatient variations of fluoropyrimidine pharmacokinetics and pharmacodynamics. Jiang H; Lu J; Jiang J; Hu P J Clin Pharmacol; 2004 Nov; 44(11):1260-72. PubMed ID: 15496644 [TBL] [Abstract][Full Text] [Related]
19. Sequential methotrexate and 5-fluorouracil: mechanisms of synergy. Bertino JR; Mini E; Fernandes DJ Semin Oncol; 1983 Jun; 10(2 Suppl 2):2-5. PubMed ID: 6867754 [TBL] [Abstract][Full Text] [Related]
20. The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine). SULLIVAN RD; YOUNG CW; MILLER E; GLATSTEIN N; CLARKSON B; BURCHENAL JH Cancer Chemother Rep; 1960 Jul; 8():77-83. PubMed ID: 13835653 [No Abstract] [Full Text] [Related] [Next] [New Search]